Ganglioside composition of a mouse brain tumor grown in the severe combined immunodeficiency (SCID) mouse (original) (raw)

• Bai H., and Seyfried T. N. (1997) Influence of ganglioside GM3 and high density lipoprotein (HDL) on the cohesion of mouse brain tumor cells.J. Lipid Res. 38, 160–172.
  PubMed CAS Google Scholar
• Bancroft G. J., Bosma M. J., Bosma G. C., and Unanue E. R. (1986) Regulation of macrophage Ia expression in mice with severe combined immunodeficiency: induction of Ia expression by a T cell-independent mechanism.J. Immunol. 137, 4–9.
  PubMed CAS Google Scholar
• Berenson C. S., Yohe H. C., and Ryan J. L. (1989) Factors mediating lipopolysaccharideinduced ganglioside expression in murine peritoneal macrophages.J. Leukocyte Biol. 45, 221–230.
  PubMed CAS Google Scholar
• Bosma M. J. and Carroll A. M. (1991) The SCID mouse mutant: definition, characterization, and potential uses.Annu. Rev. Immunol. 9, 323–350.
  Article PubMed CAS Google Scholar
• Clarke R. (1996) Human breast cancer cell line xenografts as models of breast cancer. The immunobiologies of recipient mice and the characteristics of several tumorigenic cell lines.Breast Cancer Res. Treat. 39, 69–86.
  Article PubMed CAS Google Scholar
• Cotterchio M. and Seyfried T. N. (1993) The influence of ImuVert, a biological response modifier, on the growth and ganglioside composition of murine neural tumors.Mol. Chem. Neuropathol. 20, 163–172.
  PubMed CAS Google Scholar
• Cotterchio M. and Seyfried T. N. (1994) Serum gangliosides in mice with metastatic and non-metastatic brain tumors.J. Lipid Res. 35, 10–14.
  PubMed CAS Google Scholar
• Ecsedy J. A., Manfredi M. G., Yohe H. C., and Seyfried T. N. (1997a) Ganglioside biosynthetic gene expression in murine brain tumors.Cancer Res. 57, 1580–1583.
  PubMed CAS Google Scholar
• Ecsedy J. A., Yohe H. C., and Seyfried T. N. (1997b) Glycosphingolipid composition of tumor-infiltrating macrophages in murine brain tumors.J. Neurochem. 69 (suppl.), S12D.
  Google Scholar
• El-Abbadi M. and Seyfried T. N. (1994) Influence of growth environment on the ganglioside composition of an experimental mouse brain tumor.Mol. Chem. Neuropathol. 21, 273–285.
  PubMed CAS Google Scholar
• Eto Y. and Scinoda S. (1982) Gangliosides and neutral glycolipids in human brain tumors: specificity and their significance.Adv. Exp. Med. Biol. 152, 279–290.
  PubMed CAS Google Scholar
• Evans R. and Eidlen D. M. (1981) Macrophage accumulation in transplanted tumors is not dependent on host immune responsiveness or presence of tumor-associated rejection antigens.J. Reticuloendothelial Soc. 30, 425–437.
  CAS Google Scholar
• Flavin H. J., Wieraszko A., and Seyfried T. N. (1991) Enhanced aspartate release from hippocampal slices of epileptic (El) mice.J. Neurochem. 56, 1007–1011.
  Article PubMed CAS Google Scholar
• Folch J., Lees M., and Sloane Stanley G. H. (1957) A simple method for the isolation and purification of total lipides from animal tissues.J. Biol. Chem. 226, 497–509.
  PubMed CAS Google Scholar
• Fredman P. (1988) Gangliosides in human malignant gliomas, in_New Trends in Ganglioside Research: Neurochemical and Neurogenerative Aspects_ (Ledeen R. W., Hogan E. L., Tettamanti G., Yates A., and Yu R. K., eds.) Liviana, Padova, pp. 151–161.
  Google Scholar
• Fredman P., von-Holst H., Collins V. P., Dellheden B., and Svennerholm L. (1993) Expression of gangliosides GD3 and 3′-isoLM1 in autopsy brains from patients with malignant tumors.J. Neurochem. 60, 99–105.
  Article PubMed CAS Google Scholar
• Fredman P., Wikstrand C. J., Mansson J. E., Reifenberger G., Bigner S. H., Rasheed A., Svennerholm L., and Bigner D. D. (1996) In vivo growth conditions suppress the expression of GM2 and favor that of lacto series gangliosides in the human glioma D-54MG cell line.Glyconjugate J. 3, 391–399.
  Article Google Scholar
• Furukawa K., Thampoe I. J., Yamaguchi H., and Lloyd K. O. (1989) The addition of exogenous gangliosides to cultured human cells results in the cell type-specific expression of novel surface antigens by a biosynthetic process.J. Immunol. 142, 848–854.
  PubMed CAS Google Scholar
• Jennemann R., Rodden A., Bauer B. L., Mennel H. D., and Wiegandt, H. (1990) Glycosphingolipids of human gliomas.Cancer Res. 50, 7444–7449.
  PubMed CAS Google Scholar
• Kawashima I., Ozawa H., Kotani M., Suzuki M., Kawano T., Gomibuchi M., and Tai, T. (1993) Characterization of ganglioside expression in human melanoma cells: immunological and biochemical analysis.J. Biochem. Tokyo,114, 186–193.
  PubMed CAS Google Scholar
• Lacerda J. F., Ladanyi M., Jagiello C., and O’Reilly, R. J. (1996) Administration of rabbit anti-asialo GM1 antiserum facilitates the development of human Epstein-Barr virusinduced lymphoproliferations in xenografted C.B.-17 scid/scid mice.Transplantation 61, 492–497.
  Article PubMed CAS Google Scholar
• Li J., Pearl D. K., Pfeiffer S. E., and Yates A. J. (1994) Patterns of reactivity with antiglycolipid antibodies in human primary brain tumors.J. Neurosci. Res. 39, 148–158.
  Article PubMed CAS Google Scholar
• Macala L. J. and Yohe H. C. (1995) In situ accessibility of murine macrophage gangliosides.Glycobiology 5, 67–75.
  Article PubMed CAS Google Scholar
• Phillips R. A., Jewett M. A., and Gallie B. L. (1989) Growth of human tumors in immunedeficient scid mice and nude mice.Curr. Top. Microbiol. Immunol. 152, 259–263.
  PubMed CAS Google Scholar
• Rubin R., Sutton C. H., and Zimmerman H. (1968) Experimental epencymoblastoma (fine structure).J. Neuropathol. Exp. Neurol. 27, 421–438.
  Article Google Scholar
• Sawa H., Tamaki N., and Kokunai T. (1996) Growth and immunogenicity of human glioma in severe combined immunodeficiency-human mice.Neurol. Med. Chir. Tokyo 36, 286–295.
  PubMed CAS Google Scholar
• Seyfried T. N. and Ariga T. (1992) Neutral glycolipid abnormalities in a t-complex mutant mouse embryo.Biochem. Genet. 30, 557–565.
  Article PubMed CAS Google Scholar
• Seyfried T. N., Glaser G. H., and Yu R. K. (1978) Cerebral, cerebellar, and brain stem gangliosides in mice susceptible to audiogenic seizures.J. Neurochem. 31, 21–27.
  Article PubMed CAS Google Scholar
• Seyfried T. N., Yu R. K., Saito M., and Albert M. (1987) Ganglioside composition of an experimental mouse brain tumor.Cancer Res. 47, 3538–3542.
  PubMed CAS Google Scholar
• Seyfried T. N., El-Abbadi M., and Roy M. L. (1992) Ganglioside distribution in murine neural tumors.Mol. Chem. Neuropathol. 17, 147–167.
  Article PubMed CAS Google Scholar
• Seyfried T. N., El-Abbadi M., Ecsedy J. A., Bai H. W., and Yohe H. (1996) Influence of host cell infiltration on the glycolipid content of mouse brain tumors.J. Neurochem. 66, 2026–2033.
  Article PubMed CAS Google Scholar
• Shultz L. D. (1991) Hematopoiesis and models of immunodeficiency.Semin. Immunol. 3, 397–408.
  PubMed CAS Google Scholar
• Svennerholm L. (1957) Quantitative estimation of sialic acids II. A colorimetric resorcinolhydrochloric acid method.Biochim. Biophys. Acta 24, 604–611.
  Article PubMed CAS Google Scholar
• Traylor T. D. and Hogan E. L. (1980) Gangliosides of human cerebral astrocytomas.J. Neurochem. 34, 126–131.
  Article PubMed CAS Google Scholar
• Wikstrand C. J., He X. M., Fuller G. N., Bigner S. H., Fredman P., Svennerholm L., and Bigner D. D. (1991) Occurrence of lacto series gangliosides 3′-isoLM1 and 3′, 6′-isoLD1 in human gliomas in vitro and in vivo.J. Neuropathol. Exp. Neurol. 50, 756–769.
  PubMed CAS Google Scholar
• Wikstrand C. J., Longee D. C., McLendon R. E., Fuller G. N., Friedman H. S., Fredman P., Svennerholm L., and Bigner D. D. (1993) Lactotetraose series ganglioside 3′, 6′-isoLD1 in tumors of central nervous and other systems in vitro and in vivo.Cancer Res. 53, 120–126.
  PubMed CAS Google Scholar
• Yates A. J. (1988) Glycolipids and gliomas. A review.Neurochem. Pathol. 8, 157–180.
  PubMed CAS Google Scholar
• Yates A. J., Thompson D. K., Boesel C. P., Albrightson C., and Hart R. W. (1979) Lipid composition of human neural tumors.J. Lipid Res. 20, 428–436.
  PubMed CAS Google Scholar
• Yohe H. C. and Ryan J. L. (1986) Ganglioside expression in macrophages from endotoxin responder and nonresponder mice.J. Immunol. 137, 3921–3927.
  PubMed CAS Google Scholar
• Yohe H. C., Coleman D. L., and Ryan J. L. (1985) Ganglioside alterations in stimulated murine macrophages.Biochim. Biophys. Acta 818, 81–86.
  Article PubMed CAS Google Scholar
• Yohe H. C., Cuny C. L., Macala L. J., Saito M., McMurray W. J., and Ryan J. L. (1991) The presence of sialidase-sensitive sialosylgangliotetraosyl ceramide (GM1b) in stimulated murine macrophages. Deficiency of GM1b in Escherichia coli-activated macrophages from the C3H/HeJ mouse.J. Immunol. 146, 1900–1908.
  PubMed CAS Google Scholar
• Yohe H. C., Macala L. J., Giordano G., and McMurray, W. J. (1992) GM1b and GM1b-GalNAc: major gangliosides of murine-derived macrophage-like WEHI-3 cells.Biochim. Biophys. Acta 1109, 210–217.
  Article PubMed CAS Google Scholar
• Yu R. K. and Ledeen R. W. (1970) Gas-liquid chromatographic assay of lipid-bound sialic acids: measurement of gangliosides in brain of several species.J. Lipid Res. 11, 506–516.
  PubMed CAS Google Scholar